This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Dyax Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Xinming Hao in Pediatric Hereditary Angioedema Treatment.
Introduction
Xinming Hao is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of pediatric hereditary angioedema. His innovative work has led to the development of a patent that addresses critical health issues faced by children with this condition.
Latest Patents
Xinming Hao holds a patent titled "Plasma Kallikrein Inhibitors and Uses Thereof for Treating Pediatric Hereditary Angioedema Attack." This patent represents a breakthrough in therapeutic options for managing hereditary angioedema, providing new hope for affected families. The patent showcases his dedication to improving patient outcomes through innovative solutions.
Career Highlights
Xinming Hao is currently employed at Dyax Corporation, where he continues to advance his research and development efforts. His work at Dyax Corporation has positioned him as a key player in the pharmaceutical industry, focusing on innovative treatments that address unmet medical needs. With a total of 1 patent, he has demonstrated his ability to translate scientific research into practical applications.
Collaborations
Xinming Hao collaborates with talented professionals in his field, including his coworker Christina Nurse. Their combined expertise fosters a productive environment for innovation and development, enhancing the potential for groundbreaking discoveries in the treatment of hereditary angioedema.
Conclusion
Xinming Hao's contributions to the field of pediatric hereditary angioedema treatment exemplify the impact of innovation in medicine. His patent and ongoing work at Dyax Corporation highlight the importance of research and collaboration in developing effective therapies.